1.Department of Surgery, Sunnybrook Health Sciences Centre,University of Toronto,Toronto,Canada;2.Department of Surgery, Princess Margaret Hospital,University of Toronto,Toronto,Canada
Abstract:
Background
Sentinel lymph node biopsy (SNLB) has been adopted as the standard method of axillary staging for women with clinically node-negative early-stage breast cancer. The false negative rate as a quality indicator is impractical given the need for a completion axillary dissection to calculate. The objective of this study was to develop practical quality indicators for SLNB using an expert consensus method and to determine if they were feasible to measure.